Tag Archives: Erwinase fermentation

Erwinase® sales in 2019 exceed $177 million

Erwinase fermentation

Porton Biopharma Limited (“PBL”), the UK biopharmaceutical, development and manufacturing company, notes yesterday’s full year financial results announcement from Jazz Pharmaceuticals PLC, which confirmed that Erwinase®, the Company’s life-saving cancer treatment, recorded sales of more than $177 million in 2019, up 2%.

read more